June 2015 Newsletter

June 17, 2015:

US Ophthalmic Procedures Grow by 3.1 Percent in Q1-2015; Refractive Surgery is Weak Spot

Extreme weather once again led to lost surgery days; the Glaukos iStent continued to boost the glaucoma market.

June 17, 2015:

Special Feature: Eye Surgery Network Becomes Lifeline After Nepal Quakes

Tilganga Institute of Ophthalmology is repurposed to provide disaster relief.

June 17, 2015:

Price Plays an Increasingly Important Role in LASIK Marketing

21.6 percent of patients who were offered a discount took advantage of the option in Q1-2015, according to survey respondents.

June 17, 2015:

Newer Premium IOL Technologies Expected to Fuel Global IOL Growth of 6 Percent Annually

By 2020, the revenue share for these lenses is likely to grow to more than a third of total IOL revenues.

June 17, 2015:

Germanwings Co-pilot Feared He Was Going Blind

Investigators are looking into whether medical privacy rules played a role in crash that killed 150.

June 17, 2015:

Dry Eye Clinical Trials Continue to Confound Ophthalmic Companies

Eleven Biotherapeutics is latest firm to see drug candidate falter in Phase III development.

June 17, 2015:

Utah Ban on Contact Lens Price Fixing Can Take Effect, Appeals Court Rules

Nine other states are considering similar action.

June 17, 2015:

FDA Draws Fire for Proposed Beyond Use Date for Avastin

Off-label ophthalmic use of Avastin likely would end if the agency goes forward with language proposed in draft guidance.

June 17, 2015:

Actavis plc Adopts Name of Allergan plc

Shareholders approved the name change June 5.

June 17, 2015:

June 2015 News Briefs

Social media